Drug Type Small molecule drug |
Synonyms JTE 451 |
Target |
Mechanism RORG antagonists(Nuclear receptor ROR-gamma antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | Phase 2 | US | 17 Jan 2019 | |
Plaque psoriasis | Phase 2 | CA | 17 Jan 2019 | |
Plaque psoriasis | Phase 2 | PL | 17 Jan 2019 |
Phase 2 | 152 | (JTE-451 200 mg Twice Daily) | dkwecburby(xqesdctnkr) = cswyazjhcn almrguegpg (apwulxzqbr, codwgteglc - vrdrxwktpk) View more | - | 16 Aug 2021 | ||
(JTE-451 400 mg Twice Daily) | dkwecburby(xqesdctnkr) = tjvtdgtliv almrguegpg (apwulxzqbr, srhproxukr - hextlfwbfn) View more |